https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-06-01 / Cancer Res. 2005 Jun;65(11):4947-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-06-01 / Cancer Res. 2005 Jun;65(11):4947-542005-06-01 00:00:002019-02-15 08:38:56Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-242005-04-15 00:00:002019-02-15 08:38:57Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-15 / Clin. Cancer Res. 2004 Apr;10(8):2645-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-15 / Clin. Cancer Res. 2004 Apr;10(8):2645-512004-04-15 00:00:002019-02-15 08:39:06Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-822003-12-01 00:00:002019-02-15 08:46:08Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-05-13 / World J Surg 2003 Jun;27(6):640-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-05-13 / World J Surg 2003 Jun;27(6):640-62003-05-13 00:00:002019-02-15 08:39:24Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / World J. Gastroenterol. 2003 Mar;9(3):495-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / World J. Gastroenterol. 2003 Mar;9(3):495-82003-03-01 00:00:002019-02-15 08:38:58Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-932002-07-01 00:00:002020-06-23 09:44:19Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-106
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-30 / Cancer Immunol. Immunother. 2002 Apr;51(2):99-1062002-01-30 00:00:002019-02-15 08:39:03Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-342001-07-01 00:00:002019-02-15 08:39:25Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-06-26 / Proc. Natl. Acad. Sci. U.S.A. 2001 Jul;98(15):8809-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-06-26 / Proc. Natl. Acad. Sci. U.S.A. 2001 Jul;98(15):8809-142001-06-26 00:00:002019-02-15 08:39:02Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
